| Remdesivir: review of pharmacology, pre‐clinical data, and emerging clinical experience for COVID‐19 SCJ Jorgensen, R Kebriaei, LD Dresser Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (7 …, 2020 | 264 | 2020 |
| Baricitinib: a review of pharmacology, safety, and emerging clinical experience in COVID‐19 SCJ Jorgensen, CLY Tse, L Burry, LD Dresser Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (8 …, 2020 | 205 | 2020 |
| Real-world experience with ceftazidime-avibactam for multidrug-resistant gram-negative bacterial infections SCJ Jorgensen, TD Trinh, EJ Zasowski, AM Lagnf, S Bhatia, SM Melvin, ... Open forum infectious diseases 6 (12), ofz522, 2019 | 108 | 2019 |
| Delafloxacin: place in therapy and review of microbiologic, clinical and pharmacologic properties SCJ Jorgensen, NJ Mercuro, SL Davis, MJ Rybak Infectious Diseases and Therapy 7, 197-217, 2018 | 91 | 2018 |
| Meropenem and Vaborbactam: Stepping up the battle against Carbapenem‐resistant Enterobacteriaceae SCJ Jorgensen, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (4 …, 2018 | 81 | 2018 |
| Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study SCJ Jorgensen, EJ Zasowski, TD Trinh, AM Lagnf, S Bhatia, N Sabagha, ... Clinical Infectious Diseases 71 (1), 1-10, 2020 | 76 | 2020 |
| Risk factors for early return visits to the emergency department in patients with urinary tract infection S Jorgensen, M Zurayk, S Yeung, J Terry, M Dunn, P Nieberg, ... The American Journal of Emergency Medicine 36 (1), 12-17, 2018 | 54 | 2018 |
| Real-world experience with ceftolozane-tazobactam for multidrug-resistant gram-negative bacterial infections SCJ Jorgensen, TD Trinh, EJ Zasowski, AM Lagnf, SP Simon, S Bhatia, ... Antimicrobial agents and chemotherapy 64 (4), 10.1128/aac. 02291-19, 2020 | 47 | 2020 |
| Evaluation of eravacycline: a novel fluorocycline S Alosaimy, JC Abdul‐Mutakabbir, R Kebriaei, SCJ Jorgensen, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (3 …, 2020 | 46 | 2020 |
| Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative bacterial infections S Alosaimy, SCJ Jorgensen, AM Lagnf, S Melvin, RP Mynatt, TJ Carlson, ... Open Forum Infectious Diseases 7 (3), ofaa051, 2020 | 42 | 2020 |
| Real-world, multicenter experience with meropenem-vaborbactam for gram-negative bacterial infections including carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa S Alosaimy, AM Lagnf, T Morrisette, MR Scipione, JJ Zhao, ... Open forum infectious diseases 8 (8), ofab371, 2021 | 38 | 2021 |
| Sequential intravenous-to-oral outpatient antibiotic therapy for MRSA bacteraemia: one step closer SCJ Jorgensen, AM Lagnf, S Bhatia, MD Shamim, MJ Rybak Journal of Antimicrobial Chemotherapy 74 (2), 489-498, 2019 | 36 | 2019 |
| A review of remdesivir for COVID-19 in pregnancy and lactation SCJ Jorgensen, MR Davis, SE Lapinsky Journal of Antimicrobial Chemotherapy 77 (1), 24-30, 2022 | 34 | 2022 |
| Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review SCJ Jorgensen, SE Lapinsky Clinical Microbiology and Infection 28 (1), 51-57, 2022 | 34 | 2022 |
| Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn SCJ Jorgensen, L Burry, N Tabbara Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42 (1 …, 2022 | 32 | 2022 |
| Emergency department urinary antibiograms differ by specific patient group S Jorgensen, M Zurayk, S Yeung, J Terry, M Dunn, P Nieberg, ... Journal of clinical microbiology 55 (9), 2629-2636, 2017 | 31 | 2017 |
| Teaching an old class new tricks: a novel semi-synthetic aminoglycoside, plazomicin JC Abdul-Mutakabbir, R Kebriaei, SCJ Jorgensen, MJ Rybak Infectious Diseases and Therapy 8, 155-170, 2019 | 29 | 2019 |
| Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study SCJ Jorgensen, A Hernandez, DB Fell, PC Austin, R D’Souza, ... bmj 380, 2023 | 28 | 2023 |
| A multicenter evaluation of vancomycin-associated acute kidney injury in hospitalized patients with acute bacterial skin and skin structure infections SCJ Jorgensen, KP Murray, AM Lagnf, S Melvin, S Bhatia, MD Shamim, ... Infectious diseases and therapy 9, 89-106, 2020 | 28 | 2020 |
| Leveraging antimicrobial stewardship in the emergency department to improve the quality of urinary tract infection management and outcomes SCJ Jorgensen, SL Yeung, M Zurayk, J Terry, M Dunn, P Nieberg, ... Open forum infectious diseases 5 (6), ofy101, 2018 | 27 | 2018 |
